Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million

Pharmaceutical Executive Daily: Egetis Sells Priority Review Voucher for $190 Million

Published 1 week, 6 days ago
Description
ANI Pharmaceuticals makes an offer to acquire Egetis Therapeutics as Egetis separately sells its priority review voucher for $190 million, Novartis exits its BrainTransporter deal with BioArctic 14 months after signing, and Ignite Proteomics’ Dr. Brian Corgiat on improving how tumors are tested after recurrence.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us